Table 2.
Results from dose plan analysis for Patient 1
| Obj | HT | IMP | RA | |
| PTV | ||||
| Mean [Gy] | 53.2 | 53.2 (100%) |
53.2 (100%) |
53.2 (100%) |
| D1% [%] | - | 102.3 | 107.1 | 104.9 |
| D99% [%] | - | 85.0 | 86.8 | 90.6 |
| V90% [%] | 100% | 97.7 | 97.8 | 99.3 |
| V95% [%] | 100% | 93.9 | 93.5 | 92.5 |
| V107% [%] | 0% | 0.0 | 1.1 | 0.0 |
| V110% [%] | 0% | 0.0 | 0.2 | 0.0 |
| D5–D95 [%] | - | 8.1 | 10.9 | 10.0 |
| SD [%] | - | 3.2 | 3.6 | 3.0 |
| CI90 | 1.0 | 1.2 | 1.1 | 1.2 |
| PTV scar | ||||
| Mean [Gy] | 44.8 | 46.2 (103.1%) | 44.7 (99.8%) | 45.6 (101.8%) |
| D1% [%] | - | 110.3 | 110.7 | 106.5 |
| D99% [%] | - | 96.0 | 90.6 | 94.0 |
| V90% [%] | 100% | 99.9 | 99.4 | 99.9 |
| V95% [%] | 100% | 99.5 | 88.3 | 98.4 |
| V107% [%] | 0% | 5.3 | 3.0 | 0.3 |
| V110% [%] | 0% | 1.2 | 1.2 | 0.0 |
| D5–D95 [%] | - | 7.1 | 12.3 | 7.8 |
| SD [%] | - | 2.5 | 4.0 | 2.5 |
| Vertebra | ||||
| Mean [Gy] | < 20 Gy | 17.6 | 13.6 | 22.2 |
| D1% [Gy] | Minim | 51.5 | 53.8 | 52.5 |
| Spinal Cord | ||||
| D1% [Gy] | < 45 Gy | 15.8 | 15.2 | 16.9 |
| Right Lung | ||||
| Mean [Gy] | < 15 Gy | 11.9 | 0.9 | 11.9 |
| V20 Gy [%] | Minim | 8.8 | 0.3 | 11.4 |
| Left uninvolved Lung | ||||
| Mean [Gy] | < 15 Gy | 14.1 | 6.4 | 15.5 |
| V20 Gy [%] | Minim | 20.0 | 11.8 | 25.1 |
| Heart | ||||
| Mean [Gy] | < 30 Gy | 29.1 | 3.8 | 26.7 |
| V40 Gy [%] | Minim | 11.9 | 3.2 | 10.1 |
| D1% [Gy] | Minim | 53.1 | 51.9 | 50.0 |
| Healthy tissue | ||||
| Mean [Gy] | Minim | 9.1 | 2.5 | 8.7 |
| V10 Gy [cm3] | Minim | 32.2 | 7.2 | 31.0 |
| EI [%] | Minim | 3.0 | 3.5 | 2.9 |
| DosInt [105 *Gy*cm3] | Minim | 0.84 | 0.23 | 0.81 |